Notice to the Annual General Meeting concluding the year 2024

Ilya Pharma participates at SIN UK-Northern Europe Panel on "Galvanising AMR Financing" Nov 27, British Ambassadors Residence

Stefan Roos presents at Apotekarsociteten seminar of live bacteria as pharmaceuticals November 27, online

Ilya Pharma participates in Global Scale Up program Powered by Health~Holland, Top Sector Life Sciences & Health

The Scale-up Investor Ready Program prepares entrepreneurs for the transatlantic investor market and increases the chances of successful financing.

Ilya Pharma will present poster of non-clinical data of ILP100-Oral at IBD Nordic Conference November 27-29, Malmö

Ilya Pharma selected for Sparks IPO Academy Class of 2024/2025

Open position: CFO

Ilya Pharma will present Poster with AMR data for ILP100 at US military medical partnering conference MHSRS August 26-29 August, Kissimmee, FL

Ilya Pharma will present new data in antimicrobial resistance (AMR) and the bacterial killing activity of ILP100 on multi-drug-resitant (MDR) pathogenic bacteria isolated from War victims in Ukraine.

Ilya Pharma presents clinical update at 9th Microbiome Movement Drug Development Summit, Boston 10-12 July

New publication in American Journal of Physiology Gastrointestinal and Liver on the MOA and PoC for ILP100-Oral in multiple models of colitis

The work is funded by Ilya Pharma AB, Bio-X grant from STUNS in Uppsala and the Knut and Alice Wallenberg Foundation.